Obesity, insulin resistance and diabetes: Sex differences and role of estrogen receptors
Receptor Pharmacology GLP-1R activation slows gastric emptying, stimulates glucose-dependent insulin secretion, and reduces appetite through central arcuate nucleus signaling
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved these medications following rigorous clinical trials demonstrating their efficacy in glycaemic control, with some agents (liraglutide, dulaglutide, and semaglutide) also showing cardiovascular benefits in specific populations
During this stage, the medication helps support stability instead of continuing active weight loss
This is because GLP-1 agonists can help counteract the physiological causes of weight regain, which can help reduce yo-yo weight cycling over time, Mitri adds
The follicles aren't growing new hair yet, but they're stabilizing